New research indicates that weight loss drugs, specifically GLP-1 receptor agonists, are effective for children and teenagers with obesity or type 2 diabetes. The study analyzed data from 18 clinical trials involving around 1,400 young participants, showing significant improvements in health metrics. While the drugs can lead to weight loss and better blood sugar levels, concerns about side effects and the need for longer studies persist. Experts advocate for careful prescription and support for young patients. Teljes cikk (Euronews.com)